The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms

The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms

The age-related decrease in skeletal muscle mass together with the loss of muscle power and function is defined sarcopenia. Mounting evidence suggests that the prevalence of sarcopenia is higher in patients with type 2 diabetes mellitus (T2DM), and different mechanisms may be responsible for this as...

Full description

Bibliographic Details
Main Authors: Elena Massimino, Anna Izzo, Gabriele Riccardi, Giuseppe Della Pepa
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cells
Subjects:
glucose-lowering drugs
type 2 diabetes mellitus
sarcopenia
skeletal muscle index
skeletal muscle mass
Online Access:https://www.mdpi.com/2073-4409/10/8/1958

Similar Items

Similar Items